CA50785-5 - 0x0000000000006BEB
Healthy Males & Females
Forward
* Stipend may pay up to reflected amount.
Start Date:
August 30, 2026 - 2:00pm
End Date:
September 8, 2026 - 8:30am
Study Details
Study Number: CA50785
Group Number: 5
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,250.00
Study Criteria
Age: 19 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed for the treatment of multiple sclerosis (MS).
Route of Administration: Oral
Blood Draws: 16
Study Schedule
Schedule Type: Short stays with returns
Study Length: 3 Night Stay & 2 Returns
Screening Dates:
| Event Day | Event Date |
|---|---|
| Monday | 8/17/2026 |
| Thursday | 8/20/2026 |
| Monday | 8/24/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Monday | 8/17/2026 |
| Thursday | 8/20/2026 |
| Monday | 8/24/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Sunday | 8/30/2026 2:00:00 PM | Wednesday | 9/2/2026 8:30:00 AM | 1 | Lincoln |
| Return | Friday | 9/4/2026 7:30:00 AM | Friday | 9/4/2026 8:30:00 AM | 1 | Lincoln |
| Return | Tuesday | 9/8/2026 7:30:00 AM | Tuesday | 9/8/2026 8:30:00 AM | 1 | Lincoln |
